During the past decade, CH Angoulême conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Angoulême" #1 sponsor was "Nantes University Hospital" with 6 trials, followed by "Centre Hospitalier Departemental Vendee" with 4 trials sponsored, "Poitiers University Hospital" with 4 trials sponsored, "Agennix" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Angoulême" #1 collaborator was "Ministry of Health, France" with 3 trials as a collaborator, "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 2 trials as a collaborator, "University Hospital, Tours" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "CH Angoulême" are "Severe Sepsis" (4 trials), "Alternative Method of Apnea Test" (2 trials), "Critical Illness" (2 trials), "Sepsis" (2 trials) and "Shock" (2 trials). Many other conditions were trialed in "CH Angoulême" in a lesser frequency.

Most popular intervention types in "CH Angoulême" are "Other" (8 trials), "Device" (6 trials), "Drug" (5 trials), "Procedure" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apnea test - CPAP" (2 trials), "Talactoferrin alfa" (2 trials), "2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks" (1 trials) and "Apnea test - Standard" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Angoulême" are 30 trials for "All" genders.

Currently, there are NaN active trials in "CH Angoulême". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in CH Angoulême, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH Angoulême, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".